• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降钙素基因相关肽的血管作用:一项关于人体研究的系统综述

The vascular role of CGRP: a systematic review of human studies.

作者信息

Al-Karagholi Mohammad Al-Mahdi, Kalatharan Veberka, Fagerberg Peter Schunck, Amin Faisal Mohammad

机构信息

Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Front Neurol. 2023 Jul 6;14:1204734. doi: 10.3389/fneur.2023.1204734. eCollection 2023.

DOI:10.3389/fneur.2023.1204734
PMID:37483452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10359159/
Abstract

Intravenous infusion of human alpha calcitonin gene-related peptide (h-α-CGRP) has been applied to explore migraine pathogenesis and cerebral hemodynamics during the past three decades. Cumulative data implicate h-α-CGRP in regulating the vascular tone. In this systematic review, we searched PubMed and EMBASE for clinical studies investigating the vascular changes upon intravenous infusion of h-α-CGRP in humans. A total of 386 studies were screened by title and abstract. Of these, 11 studies with 61 healthy participants and 177 participants diagnosed with migraine were included. Several studies reported hemodynamic effects including flushing, palpitation, warm sensation, heart rate (HR), mean arterial blood pressure (MABP), mean blood flow velocity of middle cerebral artery (mean V), and diameter of superficial temporal artery (STA). Upon the start of h-α-CGRP infusion, 163 of 165 (99%) participants had flushing, 98 of 155 (63%) participants reported palpitation, and 160 of 165 (97%) participants reported warm sensation. HR increased with 14%-58% and MABP decreased with 7%-12%. The mean V was decreased with 9.5%-21%, and the diameter of the STA was dilated with 41%-43%. The vascular changes lasted from 20 to >120 min. Intravenous infusion of h-α-CGRP caused a universal vasodilation without any serious adverse events. The involvement of CGRP in the systemic hemodynamic raises concerns regarding long-term blockade of CGRP in migraine patients with and without cardiovascular complications.

摘要

在过去三十年中,静脉输注人α降钙素基因相关肽(h-α-CGRP)已被用于探索偏头痛的发病机制和脑血流动力学。累积数据表明h-α-CGRP参与调节血管张力。在本系统评价中,我们在PubMed和EMBASE中检索了关于静脉输注h-α-CGRP后人体血管变化的临床研究。通过标题和摘要共筛选出386项研究。其中,纳入了11项研究,包括61名健康参与者和177名被诊断为偏头痛的参与者。几项研究报告了血流动力学效应,包括脸红、心悸、温热感、心率(HR)、平均动脉血压(MABP)、大脑中动脉平均血流速度(平均V)和颞浅动脉(STA)直径。在开始输注h-α-CGRP时,165名参与者中有163名(99%)出现脸红,155名参与者中有98名(63%)报告有心悸,165名参与者中有160名(97%)报告有温热感。HR增加14%-58%,MABP降低7%-12%。平均V降低9.5%-21%,STA直径扩张41%-43%。血管变化持续20至>120分钟。静脉输注h-α-CGRP引起全身血管舒张,无任何严重不良事件。CGRP参与全身血流动力学引发了对有和没有心血管并发症的偏头痛患者长期阻断CGRP的担忧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c4/10359159/e5ee51cf6995/fneur-14-1204734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c4/10359159/e5ee51cf6995/fneur-14-1204734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c4/10359159/e5ee51cf6995/fneur-14-1204734-g001.jpg

相似文献

1
The vascular role of CGRP: a systematic review of human studies.降钙素基因相关肽的血管作用:一项关于人体研究的系统综述
Front Neurol. 2023 Jul 6;14:1204734. doi: 10.3389/fneur.2023.1204734. eCollection 2023.
2
The Effect of K Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers.钾通道阻滞剂格列本脲对健康志愿者降钙素基因相关肽诱导的头痛及血流动力学的影响。
Front Physiol. 2021 Jun 11;12:652136. doi: 10.3389/fphys.2021.652136. eCollection 2021.
3
BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.BIBN4096BS可拮抗人α-降钙素基因相关肽诱导的头痛和脑外动脉扩张。
Clin Pharmacol Ther. 2005 Mar;77(3):202-13. doi: 10.1016/j.clpt.2004.10.001.
4
Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.舒马曲坦不会拮抗 CGRP 诱导的健康志愿者的症状。
Headache. 2020 Apr;60(4):665-676. doi: 10.1111/head.13747. Epub 2020 Jan 16.
5
Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients.降钙素基因相关肽在偏头痛中的作用:偏头痛患者的局部脑血流量和血流速度
J Headache Pain. 2008 Jun;9(3):151-7. doi: 10.1007/s10194-008-0036-8. Epub 2008 Apr 25.
6
The Influence of Calcitonin Gene-Related Peptide on Cerebral Hemodynamics in Nonmigraine Subjects with Calcitonin Gene-Related Peptide-Induced Headaches.降钙素基因相关肽诱导头痛的非偏头痛患者中降钙素基因相关肽对脑血流动力学的影响。
Biomed Res Int. 2021 Apr 24;2021:5540254. doi: 10.1155/2021/5540254. eCollection 2021.
7
Synergistic internal carotid vasodilator effects of human alpha-calcitonin gene-related peptide and nimodipine in conscious rats.人α-降钙素基因相关肽与尼莫地平对清醒大鼠颈内动脉的协同舒张血管作用
Br J Pharmacol. 1990 Apr;99(4):830-4. doi: 10.1111/j.1476-5381.1990.tb13015.x.
8
Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure.人α降钙素基因相关肽持续输注对充血性心力衰竭血流动力学、肾血流量及激素水平的影响
Am J Cardiol. 1991 Apr 1;67(8):732-6. doi: 10.1016/0002-9149(91)90531-o.
9
Carotid blood flow distribution, haemodynamics and inotropic responses following calcitonin gene-related peptide in the pig.猪降钙素基因相关肽给药后的颈动脉血流分布、血流动力学及变力反应
Eur J Pharmacol. 1995 Sep 15;284(1-2):51-60. doi: 10.1016/0014-2999(95)00366-s.
10
PACAP38 induces migraine-like attacks in patients with migraine without aura.垂体腺苷酸环化酶激活肽38(PACAP38)可诱发无先兆偏头痛患者出现偏头痛样发作。
Brain. 2009 Jan;132(Pt 1):16-25. doi: 10.1093/brain/awn307. Epub 2008 Dec 3.

引用本文的文献

1
Pain in the body, harm to the heart: advances in research on the impact of chronic pain on cardiovascular diseases.身体疼痛,心脏受损:慢性疼痛对心血管疾病影响的研究进展
Front Cardiovasc Med. 2025 Aug 6;12:1629145. doi: 10.3389/fcvm.2025.1629145. eCollection 2025.
2
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational cohort study.erenumab与其他偏头痛预防性药物对心血管和脑血管结局的影响:一项基于美国索赔数据库的观察性队列研究。
Headache. 2025 Jun;65(6):919-932. doi: 10.1111/head.14912. Epub 2025 Mar 3.
3

本文引用的文献

1
Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study.偏头痛患者使用单克隆抗 CGRP(受体)抗体治疗后的血压:一项前瞻性随访研究。
Neurology. 2022 Oct 25;99(17):e1897-e1904. doi: 10.1212/WNL.0000000000201008. Epub 2022 Oct 4.
2
CGRP-targeted drugs for migraine: still many uncertainties.用于偏头痛的降钙素基因相关肽(CGRP)靶向药物:仍存在诸多不确定性。
Lancet Neurol. 2022 Mar;21(3):209-210. doi: 10.1016/S1474-4422(21)00468-3. Epub 2022 Jan 31.
3
Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions.
Disproportionality analysis from World Health Organization data on migraine-specific medications and cerebrovascular diseases.
基于世界卫生组织关于偏头痛特异性药物和脑血管疾病数据的不成比例分析。
Eur J Clin Pharmacol. 2025 Apr;81(4):571-581. doi: 10.1007/s00228-025-03812-y. Epub 2025 Feb 24.
4
The TRPA1 Ion Channel Mediates Oxidative Stress-Related Migraine Pathogenesis.TRPA1 离子通道介导氧化应激相关偏头痛发病机制。
Molecules. 2024 Jul 18;29(14):3385. doi: 10.3390/molecules29143385.
5
K channels in cerebral hemodynamics: a systematic review of preclinical and clinical studies.脑血流动力学中的钾通道:临床前和临床研究的系统评价
Front Neurol. 2024 Jul 3;15:1417421. doi: 10.3389/fneur.2024.1417421. eCollection 2024.
6
CGRP Antagonism and Ketogenic Diet in the Treatment of Migraine.降钙素基因相关肽(CGRP)拮抗剂与生酮饮食治疗偏头痛。
Medicina (Kaunas). 2024 Jan 15;60(1):163. doi: 10.3390/medicina60010163.
降钙素基因相关肽靶向药物治疗偏头痛:药理学如何为治疗决策提供信息。
Lancet Neurol. 2022 Mar;21(3):284-294. doi: 10.1016/S1474-4422(21)00409-9. Epub 2022 Jan 31.
4
Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data.依瑞奈尤单抗治疗偏头痛患者的高血压风险:临床试验和上市后数据的分析。
Headache. 2021 Oct;61(9):1411-1420. doi: 10.1111/head.14208. Epub 2021 Sep 30.
5
Calcitonin gene-related peptide-induced hemodynamic changes in migraine with and without aura.降钙素基因相关肽诱导有先兆和无先兆偏头痛的血液动力学变化。
Acta Neurol Scand. 2021 Dec;144(6):616-622. doi: 10.1111/ane.13495. Epub 2021 Jul 6.
6
The Effect of K Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers.钾通道阻滞剂格列本脲对健康志愿者降钙素基因相关肽诱导的头痛及血流动力学的影响。
Front Physiol. 2021 Jun 11;12:652136. doi: 10.3389/fphys.2021.652136. eCollection 2021.
7
CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells.降钙素基因相关肽、肾上腺髓质素和肾上腺髓质素 2 在原代人心血管细胞中表现出内源性 GPCR 激动剂偏向性。
Commun Biol. 2021 Jun 23;4(1):776. doi: 10.1038/s42003-021-02293-w.
8
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.两项单发作 3 期随机试验:ACHIEVE I 和 II 中主要心血管危险因素参与者中ubrogepant 的安全性和疗效。
Cephalalgia. 2021 Aug;41(9):979-990. doi: 10.1177/03331024211000311. Epub 2021 Apr 19.
9
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
10
Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients.胰淀素类似物普兰林肽可诱发患者偏头痛样发作。
Ann Neurol. 2021 Jun;89(6):1157-1171. doi: 10.1002/ana.26072. Epub 2021 Apr 8.